This website uses cookies

This websites contains videos from YouTube. This company uses cookies (third party cookies). If you do not want them to use these cookies, you can indicate so here. However, this does mean that you will not be able to watch videos on this website. We also make use of our own cookies in order to improve our website. We don't share our data with other parties. Which cookies are involved?

This website uses cookies to enable video and to improve the user experience. If you do not want to accept these cookies, indicate so here. Which cookies are involved?

Ga direct naar de inhoud, het hoofdmenu, het servicemenu of het zoekveld.

Back to overview

Lindy L. Visser, MSc. group

Visser, Lindy

Lindy L. Visser, MSc.

Ph.D. Student

Personal details

Experience

August 2013, I achieved a master degree in Oncology at VU University Amsterdam. Today, I'm a PhD student studying ductal carcinoma in situ (DCIS) of the breast. Population-based breast cancer screening and implementation of digital mammography has resulted in an increased incidence of DCIS, but not in a decreased incidence of advanced breast cancer, suggesting overtreatment of DCIS lesions. Within this study I'm aiming to find biomarkers to distinguish harmless from aggressive lesions. Subsequently, these accurate biomarkers may aid to decide which woman should be treated and which one not, which creates the potential of sparing these patients intensive treatment.

 

Share this page